HPLC Purity vs MS Identity: What Each Test Proves

Almost every peptide certificate carries two results: a purity figure from high-performance liquid chromatography (HPLC) and an identity result from mass spectrometry (MS). They sit next to each other in the table, and buyers tend to read them as two views of one fact, "the peptide is good". They are not. HPLC answers the question how much of what the detector saw is one thing; MS answers the question does that thing have the mass we expected. Each can pass while the other fails, and each is blind to a class of problems the other can catch.

This guide takes the two measurements apart. It explains, without assuming laboratory experience, how each number is produced, what it rules out, what it leaves open, and how to read the two together. The worked examples use public lot records from Pepti's library, because those records can be opened by anyone and compared with independent databases, and because they illustrate, honestly, how reporting conventions vary even within one supplier's documents.

Two questions, two instruments

Start with the vocabulary, because the confusion usually begins there.

Purity is a statement about composition: of the material that was analyzed, what fraction is the intended compound and what fraction is something else. On peptide certificates it is nearly always measured by reversed-phase HPLC with ultraviolet detection and expressed as area-percent.

Identity is a statement about the main component: is it the molecule the label names? On peptide certificates it is nearly always a molecular-weight check by mass spectrometry, sometimes supported by retention time against a reference standard.

Content (or assay) is a third statement, often absent: how much of the compound is present by weight. It is not the subject of this guide beyond noting that neither HPLC area-percent nor MS gives it; the purity guide covers it.

The two instruments are frequently combined into one system (LC-MS), in which the chromatograph separates the sample and the mass spectrometer reads each peak as it elutes. That combination is the most informative routine analysis available for peptides, and when a certificate says "LC-MS" it is worth asking whether both the chromatogram and the spectrum are available, because the combination is only as useful as the parts you can see.

How HPLC produces a purity number

A reversed-phase HPLC run works like this. A small volume of dissolved sample is introduced into a stream of solvent (the mobile phase) flowing through a tube packed with chemically modified silica particles (the column, most often C18). Peptides stick to the particles to a degree that depends on how hydrophobic they are. The mobile phase starts mostly aqueous and is made progressively more organic over the run (gradient elution), so that components release from the column in order of increasing hydrophobicity and arrive at a detector one after another. The detector is usually an ultraviolet absorbance detector set near 214 nm, the wavelength at which the peptide bond absorbs; 220 nm and 280 nm are also used.

The output is a chromatogram: absorbance against time. Each component is a peak. Software draws a baseline, decides where each peak begins and ends, and integrates the area under each. Area-percent purity is the main peak's area divided by the sum of all peak areas, multiplied by 100.

Every word of that description is a variable that changes the number:

• The column chemistry and particle size set how well similar peptides separate.
• The gradient (how fast the organic fraction rises) sets whether near neighbors resolve into separate peaks or merge into one. Steeper gradients produce higher purity figures from the same vial.
• The wavelength sets what is seen. At 214 nm every peptide bond contributes; at 280 nm only tryptophan and tyrosine side chains do, so impurities lacking those residues disappear.
• The run length sets whether slowly eluting material is counted at all.
• The integration settings set whether small peaks near the baseline are included in the denominator.

A recent study in the Journal of Peptide Science that systematically varied these parameters on a defined peptide impurity library found that flow rate and the choice of mobile-phase modifier had the largest effect on separation quality, and that method transfer between systems introduced elution errors of around 17% before correction. The practical conclusion for a reader of certificates is simple: a purity figure without its method is a number without units.

What HPLC purity proves

Within its limits, HPLC area-percent is a good measurement, and it is worth being clear about what it does establish.

It establishes that, under the stated conditions, the main component accounted for the stated share of the ultraviolet-absorbing material that eluted. If the method has adequate resolution for the impurities that matter, that figure is a fair proxy for chromatographic purity, and changes in it between lots or over time are meaningful. ICH Q2(R2), the international text on validating analytical procedures, lists the properties a method must demonstrate before its results can be relied on: specificity, range, accuracy, precision and, for impurity methods, limits of detection and quantitation. A purity figure from a validated method with system-suitability checks on the day is a result; the same figure from an undocumented run is an observation.

It also establishes something about the impurity profile, if the chromatogram is available. The number, size and position of the minor peaks tell an experienced reader whether the impurities look like synthesis-related material (deletion sequences and incompletely deprotected species cluster near the main peak), degradation products (oxidized or deamidated forms, often slightly earlier or later), or something unrelated.

What HPLC purity does not prove

Four blind spots, in descending order of how often they matter.

It does not confirm identity. A chromatogram shows that one component dominates. It does not show what that component is. A vial of the wrong peptide, made cleanly, gives a beautiful chromatogram. Retention time against a reference standard adds some identity information, but only if a standard was run on the same system, and research-use certificates rarely say so. Verbeke and colleagues, examining synthetic peptides supplied for research with certificates stating at least 95% purity, found that the main compound of one sample "was even found to have a different structure compared to the desired peptide". HPLC alone would not have caught it.

It does not measure content. Water, counter-ions (trifluoroacetate or acetate), and inorganic salts do not absorb at 214 nm and do not appear in the chromatogram. A lyophilized vial can be 99% pure by HPLC while peptide makes up a considerably smaller fraction of its gross weight. The two figures are not in conflict; they measure different things.

It cannot see what co-elutes. If an impurity leaves the column at the same time as the main peptide, their peaks merge and the impurity is counted as product. Diastereomers (the same sequence with one residue in the opposite stereochemical form) and aspartyl isomers (α- and β-aspartate forms produced via aspartimide intermediates during synthesis) are the classic cases: similar enough in hydrophobicity to co-elute on a routine gradient, identical in mass, and therefore invisible to both HPLC and MS unless the method is specifically designed to separate them. Photodiode-array peak-purity analysis can flag some co-elution; it is rarely reported on research-use certificates.

It is method-dependent. The same vial, two methods, two different figures, both correct. Comparing purity figures across suppliers without comparing methods is comparing apples with pears.

How mass spectrometry confirms identity

A mass spectrometer measures the mass-to-charge ratio of ions. For peptides the ions are usually made by electrospray ionization (ESI), in which the dissolved sample is sprayed through a charged needle and the droplets evaporate to leave peptide molecules carrying one or more extra protons. A peptide of neutral mass M carrying n protons appears at a mass-to-charge value of (M + n × 1.007)/n. Larger peptides pick up several protons, so the spectrum shows a series of peaks at different charge states; software combines them into a single molecular-weight value, a step called deconvolution. Matrix-assisted laser desorption/ionization (MALDI-TOF) is an alternative that mostly produces singly charged ions and reads the mass more directly, with somewhat lower precision for large peptides.

Two conventions govern the expected value, and a certificate should say which it used:

• Monoisotopic mass is calculated using the most abundant isotope of each element. It is what a high-resolution instrument reports for small peptides, where the first isotope peak dominates.
• Average mass is calculated using the natural isotopic abundance of each element. For large peptides, where the isotope envelope spreads over several daltons and the monoisotopic peak is small, the average is the natural figure to report.

The two differ by roughly one dalton per thousand: for a 1,400 Da peptide, about 0.8 Da; for a 4,800 Da peptide, about 2.5 Da. Add the possibility that a laboratory reports the protonated ion (M + 1.007) rather than the neutral molecule, and it becomes clear why a reader comparing a certificate with PubChem can see small, alarming-looking discrepancies that mean nothing more than a difference in convention.

What MS proves and does not

MS proves that a molecule with the expected mass is present in the sample, within the instrument's mass accuracy. Combined with a clean chromatogram, that is strong evidence the main component is the intended peptide, because an unrelated contaminant is unlikely to share its mass. Tandem MS (MS/MS), in which the ion is fragmented and the fragments are weighed, can go further and confirm the sequence; it appears on some laboratory reports and almost never on routine certificates.

MS does not prove purity. Ion signal is not proportional to amount in any simple way, because different molecules ionize with different efficiency. A spectrum dominated by the expected mass is consistent with high purity but does not measure it.

MS cannot see impurities with the same mass as the target. These are not exotic:

• A diastereomer (one D-amino acid in place of L) has an identical mass.
• Aspartyl isomers formed through aspartimide intermediates during synthesis have an identical mass; a 2019 report in the Journal of Peptide Science describes the aspartimide problem as persisting in standard Fmoc chemistry, and a 2022 study needed cyclic ion-mobility mass spectrometry, an advanced technique, to localize aspartic acid isomers in peptides at all.
• A deamidated residue (asparagine to aspartate) adds only about 0.98 Da, which a low-resolution instrument may not separate from the main isotope envelope.
• Oxidation of methionine adds 16 Da; that one MS does see, as a satellite peak.

Deletion sequences and truncations, by contrast, differ in mass by at least one residue (57 Da for glycine, more for others) and are easy for MS to detect as separate peaks, if the report shows the whole spectrum rather than one number.

Reading the two results together

Put the two measurements in a grid and the logic becomes mechanical.

The second row deserves emphasis. A certificate with 99.5% purity and a molecular weight that does not correspond to the named compound is not "mostly fine". Either the certificate is wrong or the material is, and both possibilities are worse than a low purity figure.

The first row is where most certificates sit, and the habit to form is to read it as "two tests passed" rather than "the peptide is good". What the pair leaves open is exactly the list from the previous sections: content, water, counter-ion, isobaric impurities, and anything the method's resolution could not separate.

Worked examples: conventions in real records

Pepti's public library reports an MS molecular-weight result on every lot record. Reading several of them against PubChem shows how conventions vary in practice, which is useful precisely because the records are real and the differences are instructive rather than sinister.

Ipamorelin, lot PEP260707-IPA10. The record reports 711.35 Da. PubChem lists ipamorelin's monoisotopic mass as 711.386 and its average molecular weight as 711.9. The reported value is the monoisotopic mass to within about 0.04 Da, consistent with a high-resolution ESI measurement reported as the neutral monoisotopic value.

BPC-157, lot PEP260628-BPC10. The record reports 1418.5 Da. PubChem gives a monoisotopic mass of 1418.70 and an average weight of 1419.5. The reported value is the monoisotopic mass, rounded or measured with a few tenths of a dalton of error.

BPC-157, lot PEP260707-BPC2. The record for a different lot of the same compound reports 1420.51 Da. That is the average mass plus one proton (1419.5 + 1.007 = 1420.5): the protonated ion reported as the result. Same compound, same supplier, two lots, two conventions. Neither is wrong, and a reader who did not know the conventions might conclude that the two lots contain different molecules. They do not.

Tirzepatide, lot PEP260706-TR10. The record reports 4813.32 Da against a PubChem average weight of 4813: the average-mass convention, as is usual for a peptide of this size.

GHK-Cu, lot PEP260704-CU50. The record reports "401.91 Da neutral; 402.92 m/z [M+H]+". This is the format to prefer: it states the neutral mass and the observed protonated ion separately and labels both, so no inference is needed.

The lesson is not that the library is inconsistent, though it would be tidier if every record used the GHK-Cu format. The lesson is that an MS identity result is only readable if you know the convention, and a certificate that states the convention saves you the detective work. When you see a result that is about one dalton off the PubChem figure, think "protonated ion" before you think "wrong compound".

What a fuller analytical package adds

If you are moving from a first order to a standing supply, or if content matters for your work, the two-test certificate can be supplemented. In rough order of availability:

1. The chromatogram itself, with integration marks, so you can see the minor peaks and the baseline. Many manufacturers will send it on request; some, like the library used here, link the full COA PDF from the record.
2. LC-MS with the spectrum shown, so that minor peaks in the chromatogram can be assigned a mass and therefore an origin (a −87 Da peak is a serine deletion; +16 is oxidation).
3. Peak purity by photodiode array, to flag co-elution under the main peak.
4. Related substances table, listing each impurity above a threshold by retention time and percentage.
5. Net peptide content by amino acid analysis or nitrogen determination, to convert gross weight to peptide weight.
6. Counter-ion and water content, which with content closes the mass balance.
7. Sequence confirmation by MS/MS, which converts "a molecule of the right mass" into "the right sequence".

Items 5 to 7 are routine in regulated manufacturing and rare in research-use supply; asking for them tells you quickly whether a supplier is a manufacturer with a laboratory or a reseller forwarding documents.

Questions to ask about methods

When a supplier's certificate gives a purity figure and an identity result, these questions, asked once, tell you most of what you need about how the figures were produced. None requires a specialist to ask.

• Which HPLC method: column, gradient length, detection wavelength? Is the chromatogram available?
• Is the purity figure area-percent at a single wavelength, and were all peaks above a stated threshold integrated?
• Was a reference standard run alongside, and is retention time matched?
• Which MS technique, and is the reported value monoisotopic, average, neutral or protonated?
• Is the full spectrum available, and does it show any satellite peaks (+16, −18, +22)?
• Were the HPLC and MS results obtained on this lot, on this date, and are the raw data files retained?

A manufacturer that runs its own laboratory can answer in a day. A reseller will have to ask the manufacturer, which is itself useful information.

Maintained by Pepti, a Guangzhou peptide manufacturer; lot records referenced here are published at peptioem.com/coa. This guide is informational and does not sell or recommend specific vendors. Corrections: contact.